Since 1967, the Respiratory Research Center at The Lundquist Institute for Biomedical Innovation has conducted clinical and translational research to develop new therapies for patients with chronic lung diseases and other conditions that limit exercise tolerance.
Welcome to Respiratory Research Center, a full-service respiratory diagnostic and investigative medicine research clinic located at The Lundquist Institute on the campus of Harbor/UCLA Medical Center. We research chronic lung diseases that inhibit the quality of life for our research participants.
We are dedicated to researching chronic respiratory diseases that affect people around the world. Learn More
Our Core Lab clinical trial central reading processes and documentation are FDA compliant. Learn More
Researching exercise intolerance improves the lives of patients both physically and mentally. Learn More
Respiratory diseases affect people all over the world and in every walk of life. From the young to the elderly, respiratory diseases such as emphysema and chronic bronchitis (COPD) and asthma, reduce the quality of life for otherwise healthy individuals. Shortness of breath and exercise intolerance impair a persons ability to stay active and live a healthy lifestyle.
Our commitment is to improve the quality and duration of life for those suffering from respiratory diseases. Through partnerships with the National Institutes for Health (NIH), industry, healthcare providers, foundations, and our study participants we continue to contribute to medical advancements.
It is the people who make the Respiratory Research Center what it is today and we are extremely proud of the achievements of our research investigators and staff. We all work together to discover new treatments to improve the quality and duration of life for those suffering from respiratory diseases.
We at the Respiratory Research Center aim to improve the lives of people with respiratory disease. Our research investigators are world-renowned
in their experience with understanding respiratory health. Our researchers have decades of experience conducting clinical trials that have lead to respiratory treatment discoveries.
Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs.
Pulmonary rehabilitation (PR) is a supervised medical program that helps people who have lung diseases live and breathe better.
Pulmonary Hypertension (PH) is a disease of high blood pressure in your pulmonary artery. This is the large artery that leaves the heart and goes to your lungs.
The CDC uses the term “Long Haul COVID” to describe post-COVID health issues that persist more than four weeks after a person is first infected
Asthma is a condition in which your airways narrow and swell and may produce extra mucus. This can make breathing difficult and trigger coughing, a whistling sound (wheezing)
Shortness-of-breath, or Dyspnea, is a common symptom that causes exercise limitation or “intolerance”. Breathlessness during exercise is often
There are many reasons why individuals may lose strength, but in many patients with chronic heart, lung or kidney diseases the loss of muscle mass and strength is faster than normal.